Concepedia

Publication | Open Access

Effect on Glycemic Control of Exenatide (Synthetic Exendin-4) Additive to Existing Metformin and/or Sulfonylurea Treatment in Patients With Type 2 Diabetes

DOIFull Paper Access

355

Citations

33

References

2003

Year

Mark Fineman, Thomas A. Bicsak, Larry Z. Shen, Kristin Taylor, Eling Gaines, Amanda Varns, Dennis Kim, Alain Baron
Diabetes Care

Abstract

AC2993 is a promising therapeutic for patients with type 2 diabetes. In this study, it had significant effects on HbA(1c) levels in patients not currently achieving optimal glucose control with diet and/or OAAs.

References

YearCitations

Page 1